Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Present And Forecasted Size Of The Cardiac Biomarkers Market?

There has been a fast-paced expansion in the cardiac biomarkers market in the past few years. The market is set to increase from $18.99 billion in 2024 to $21.19 billion in 2025, showing a Compound Annual Growth Rate (CAGR) of 11.6%. This growth in the historical period is due to the rise in healthcare spending, approvals received from the FDA, supportive regulations, growing elderly population, awareness drives, highly sensitive troponin tests, and the surge in cardiovascular diseases.

The market size for cardiac biomarkers is anticipated to experience swift expansion in the upcoming years, with projections indicating its enlargement to $36.55 billion by 2029 at a 14.6% compound annual growth rate (CAGR). This projected acceleration during the forecast period is primarily linked to the escalating prevalence of chronic diseases, the intense focus on early detection of diseases, the expansion of the elderly population, advancements taking place in emerging markets, and an emphasis on biomarker panels. Key trends to observe during the forecast period encompass patient-oriented healthcare models, the application of AI and machine learning, the integration of digital health, technological breakthroughs in biomarker detection, multi-marker panels, and the application of liquid biopsy in cardiovascular medicine.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10234&type=smp

What Drivers Are Accelerating Expansion Of The Cardiac Biomarkers Market?

Owing to the increasing incidence of cardiovascular ailments, the cardiac biomarker market is anticipated to see substantial growth. Cardiovascular conditions, which include coronary artery disease, heart failure, and stroke, impact the heart and blood vessels. Cardiovascular disorders like myocardial infarction (heart attack), heart failure, and arrhythmias trigger the release of cardiac biomarkers into the bloodstream. Laboratory tests can measure these biomarkers, providing valuable diagnostic and prognostic data. An example being, data from the British Heart Foundation, a UK-based cardiovascular research charity, revealed in September 2024 that nearly 7.6 million people in the UK suffer from heart and circulatory diseases. This includes about 4 million men and 3.6 million women. Cardiovascular diseases account for approximately 27% of all UK deaths, adding up to over 170,000 deaths each year, or around 480 daily deaths. This equals a death every three minutes. Hence, this growing incidence of cardiovascular ailments is fuelling the expansion of the cardiac biomarker market.

What Are The Primary Segmentation Parameters In The Cardiac Biomarkers Market?

The cardiac biomarkersmarket covered in this report is segmented –

1) By Biomarkers Type: Creatine Kinase (CK-Mb), Troponins, Myoglobin, Natriuretic Peptides (BNP And NT-proBNP), Ischemia Modified Albumin (IMA), Other Biomarker Types

2) By Location Of Testing: Point Of Care Testing, Laboratory Testing

3) By Application: Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome (ACS), Atherosclerosis, Other Applications

4) By End User: Hospitals, Specialty Clinics

Subsegments:

1) By Creatine Kinase (CK-Mb): CK-Mb Test Kits, CK-Mb Diagnostic Panels

2) By Troponins: Troponin I Test Kits, Troponin T Test Kits, Troponin Diagnostic Panels

3) By Myoglobin: Myoglobin Test Kits, Myoglobin Diagnostic Panels

4) By Natriuretic Peptides (BNP And NT-proBNP): BNP Test Kits, NT-ProBNP Test Kits, Natriuretic Peptides Diagnostic Panels

5) By Ischemia Modified Albumin (IMA): IMA Test Kits, IMA Diagnostic Panels

6) By Other Biomarker Types: Heart Fatty Acid Binding Protein (HFABP), C-Reactive Protein (CRP), Other Emerging Biomarkers

Which Emerging Trends Are Reshaping The Cardiac Biomarkers Market Landscape?

Advancements in technology are progressively becoming a central trend in the cardiac biomarker market. To maintain their standing in this sector, companies are embracing novel technologies. For instance, in October 2023, China’s medical devices business, Mindray, rolled out new high-sensitivity cardiac biomarkers troponin I (hs-cTnI) and NT-proBNP. These are geared towards elevating the diagnosis and handling of cardiovascular diseases (CVDs). The hs-cTnI biomarker is crucial in pinpointing myocardial injury, demonstrating an impressive detection rate and negligible imprecision hence making it indispensable in preliminary screenings and risk evaluation in scenarios such as Acute Coronary Syndrome (ACS). On the contrary, NT-proBNP, a reputable marker for heart failure, aids in its detection and management and displays superior precision with minimal disruption from common heart medications. Collectively, these biomarkers considerably enhance clinical decision-making in critical cardiovascular treatments.

Which Players Are Shaping The Competitive Landscape Of The Cardiac Biomarkers Market?

Major companies operating in the cardiac biomarkers market include bioMerieux Inc., Bio-Rad Laboratories, F. Hoffmann-La Roche AG, Siemens AG, Thermo Fisher Scientific Inc., Creative Diagnostics, Randox Laboratories Ltd., Becton Dickinson and Company, Tosoh Corporation, Life Diagnostics, PerkinElmer Inc., Quidel Corporation, ACS Biomarker BV, LSI Medience Corp., BioDot, Alere Inc., Biosensors International Group, Biosynex SA, CardioGenics Holdings Inc., Danaher Corporation, Cortez Diagnostics Inc., DIALAB GmbH, Eurolyser Diagnostica GmbH, Grifols SA, Hologic Inc., InfraRedx Inc., Labcorp Corp., Lepu Medical Technology, Myriad Genetics, Nanosphere Inc., Biora Therapeutics Inc., Quest Diagnostics

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-global-market-report

What Are The Emerging Regional Trends Driving The Cardiac Biomarkers Market?

North America was the largest region in the cardiac biomarkers market in 2024. The regions covered in the cardiac biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=10234&type=smp

Browse Through More Reports Similar to the Global Cardiac Biomarkers Market 2025, By The Business Research Company

Pacemakers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pacemakers-global-market-report

Cardiac Assist Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiac-assist-devices-and-equipment-global-market-report

Cardiac Rhythm Management Crm Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiac-rhythm-management-crm-devices-and-equipment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model